Aggrecan, together with type II collagen, makes up to 90% of the dry weight of healthy cartilage. It hydrates the collagen network and thus provides cartilage with its properties of compressibility and elasticity. The N-terminal region of human Aggrecan (residues 20-675) consists of two globular domains (G1 and G2), flanking an interglobular domain (IGD). The IGD contains the cleavage sites for matrix metalloproteinases and aggrecanases.
应用类型
WB, IHC (P)
免疫原
该Anti-Human Aggrecan的详细信息查看ReliaTech提供的产品说明书。
来源宿主
该Anti-Human Aggrecan的详细信息查看ReliaTech提供的产品说明书。
反应性
该Anti-Human Aggrecan的详细信息查看ReliaTech提供的产品说明书。
保存建议
该Anti-Human Aggrecan的详细信息查看ReliaTech提供的产品说明书。溶解建议：Centrifuge vial prior to opening. Reconstitute the antibody with 500 µl sterile PBS and the final concentration is 200 µg/ml.
